Why the Best Way to Train a Surgeon Is in Virtual Reality ft. Justin Barad, Osso VR
The AI XR Podcast.Show Notes
Justin Barad is a pediatric orthopedic surgeon, a former Activision game developer, and the founder of Osso VR — one of the few companies in XR that has quietly built a real, profitable business while most of the industry was still searching for one. He joins Charlie and Ted to talk about why virtual reality turned out to be uniquely suited to medical training, and why the way we train surgeons today is still built on a model developed in the 1800s by a brilliant doctor with a serious drug problem.
The core argument of the episode is simple: you should not practice on patients. The aviation industry figured this out decades ago — pilots recertify in simulators, not planes. Medicine has been slower to get there, but Osso VR is making the case with data. Nine published studies. Used in 50 countries. Over 300 training modules. And an objective assessment system that, in one study, showed a 230% performance difference between surgeons measured to be competent and surgeons who simply felt ready.
Justin and Ted go deep on why objective assessment is the real power of the technology, not the immersion. They talk about why the residency model hasn't fundamentally changed since the 1890s, what it would take to actually shorten the 14-year road to becoming a surgeon, and why the company's most exciting growth right now isn't surgeons at all — it's nurses and allied health professionals, a market that dwarfs surgery by a factor of ten. The episode closes on an honest look back at 2016, when everyone in XR thought they were a year or two away from changing everything, and what Justin learned from being one of the first people to test those assumptions against reality.
Brought to you by Zappar and Mattercraft, the leading visual development environment for immersive 3D web experiences. Start building at mattercraft.io. Hosted on Acast. See acast.com/privacy for more information.
More from The AI XR Podcast.
Ted and Charlie open with a news roundup covering Colossal Biosciences’ real-world take on a Snow Crash robotic companion, a secretly recorded OpenAI meeting, and the wave of tech billionaires suddenly pledging away chunks of their fortunes. From there they dig into Robert Downey Jr. joining Snap, the relaunch of VR fitness app Supernatural, and why training and simulation keep proving to be VR’s most durable use case.
Ted and Charlie open with a quieter AI news week, giving them room to dig into XR hardware, including hands-on impressions of two new smart glasses, a Norway story on camera glasses restrictions, the shutdown of the XR Association, backlash over Meta’s Muse app, and a tour through AI’s fast-moving film scene.
Charlie, Ted, and Rony open on the week's AI political theater, from the sudden rebrand of AI to "superintelligence" to Dario Amodei's uncomfortable White House appearance. From there, the conversation covers AMD's acquisition of Fei-Fei Li's World Labs, the curious divergence between OpenAI's and Anthropic's paths toward going public, and Rony's read on why liability risk may be the real story behind both. They also dig into Nvidia's push to regulate AI safety at the chip level, a stranger-than-fiction report about Anthropic bringing religious leaders in to discuss whether Claude might be conscious, OpenAI's new companion AI "Dots," and a candid look at where consumer VR actually stands right now.
Cortney Harding steps in as guest co-host this week, joining Charlie to unpack a genuinely strong Meta Connect, new occluded VR glasses aimed squarely at the Vision Pro, a camera-free Ray-Ban, and Muse AI's surprise climb to the top of the app stores. From there, the conversation turns to Disney's newly created CTO role, the quiet fate of its big-money bets on Epic Games and Sora, and Jeffrey Katzenberg's open letter arguing entertainment has always been a technology business. They close out the news with a sharp exchange on Amazon's push into drone delivery and a pointed critique of DraftKings' use of AI to target its most engaged, and most vulnerable, customers.
Charlie and Rony open with Charlie's hands-on take on Snap's $2,200 Specs launch and Rony's theory on how big tech companies let smaller players pioneer risky new hardware first. From there, the conversation turns to a tense week in AI safety, sparked by Dario Amodei's call for frontier labs to slow down, and a sharp debate over whether the industry's talk of needing regulation is really about something else entirely. They close out the news with a look at how China is approaching AI development differently than the West, plus a genuinely stunning breakthrough in brain-computer interfaces.